University of Nottingham, United Kingdom
Professor of Molecular Microbiology, School of Life Sciences, University of Nottingham. He has 24 years of expertise in the study of molecular mechanisms of quorum sensing-based control of gene expression in bacteria, how it influences the behaviour of polymicrobial communities and their interaction with mammalian hosts and eukaryotic organisms. He has also been working on the identification of novel antimicrobial targets and coordinated several international antimicrobial programmes mainly focused on quorum sensing inhibition as the main target.
Miguel Cámara completed his Fundamental Biology BSc (Hons) Degree at the Complutense University in Madrid (Spain) in 1988. He moved to the University of Leicester where he completed a Biotechnology Diploma in 1989 followed by his PhD in 1992. After two postdoctal periods in the UK he was appointed as Lecturer in the School of Pharmacy at Nottingham University in 1996, to Senior Lecturer in 2002. In 2004 he moved to the School of Molecular Medical Sciences where he was promoted to Reader in 2005 and to full Professor in Molecular Microbiology in 2009 and in 2013 joined the newly formed School of Life Sciences.
He has supervised more than 44 PhDs and has >120 publications in peer reviewed journals (Citations 17,079, H-index 57). He is also co-director of the new £26M UK National Biofilms Innovation Centre funded by BBSRC, Innovate UK and Industry and is a member of the UK Cystic Fibrosis Trust Strategic Implementation Board.
Central European Symposium on Antimicrobials and Antimicrobial Resistance
